An Integrated Approach for Early In Vitro Sedation Prediction Utilizing hiPSC Neurons and Human Ion Channel Assays
Central nervous system (CNS) liabilities remain a significant cause of failure in drug development. Two complementary in vitro safety assays were previously developed, combining automated patch-clamp electrophysiology and multielectrode array techniques, to detect and avoid seizurogenic compounds. Further to seizure risk, sedation and fatigue are commonly encountered CNS side effects during drug safety testing. Here, the aim was to extend the capability of the in vitro safety assay to enable earlier detection of sedative potential. Fourteen compounds with reported sedative activity and five non-sedative controls were screened in human-induced pluripotent stem cell-derived neurons using multielectrode array. These compounds were further screened with automated patch-clamp electrophysiology using cells expressing CNS ion channels implicated in sedation: K V 1.1, K V 2.1, K V 3.1, K V 7.2/7.3, Na V 1.2, K 2P 2.1, or the α 1 β 2 γ 2 GABA A , and α 4 β 2 nicotinic receptors. Known sedative compounds reduced neural firing and network burst activity in human-induced pluripotent stem cell-neurons, indicating sedative effects, whilst negative control compounds did not significantly change multielectrode array parameters. Of the 19 compounds screened, 94% were accurately classified. Automated patch-clamp electrophysiology confirmed that several sedative compounds interacted with CNS ion channels within a 30-fold margin to their total therapeutic blood plasma concentration. These results support the use of the combined in vitro safety models for detecting sedative as well as seizurogenic effects, offering valuable human-based tools for early hazard identification and prioritization of drug candidates. These platforms are also useful for interpretation of CNS-related findings in vivo supporting the principles of 3Rs to minimize and replace the use of animals in scientific testing.
Authors
- Katie Newman
- Louisa Zolkiewski (ORCID: https://orcid.org/0000-0002-9205-3358)
- Magali-Anne Maizières
- Michael J. Morton (ORCID: https://orcid.org/0000-0002-7443-8828)
- Kimberly L. Rockley
- Ruth Angela Roberts (ORCID: https://orcid.org/0000-0002-7763-7558)
- Bethan Kelly
- Hannah G. Jennings (ORCID: https://orcid.org/0000-0003-0686-3694)
- Karen Jones
Institutions
- University of Birmingham (GB)
Publication Details
- Journal
- International Journal of Toxicology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1177/10915818261494181
- Primary Topic
- Animal testing and alternatives
- Type
- article
- Field-Weighted Citation Impact
- 0.00